¼¼°è ÁöÇ÷ ½ºÇÁ·¹ÀÌ ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°
Hemostatic Spray Market, By Product Type, By Application, By End User, By Geography
»óǰÄÚµå : 1392079
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2023³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,440,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,018,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,312,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ÁöÇ÷ ½ºÇÁ·¹ÀÌ ½ÃÀå ±Ô¸ð´Â 2023³â 25¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í 2030³â¿¡´Â 46¾ï 9,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 9.3%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ´ë»ó ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁسâ 2022³â 2023³â ½ÃÀå ±Ô¸ð 25¾ï 1,000¸¸ ´Þ·¯
¾÷Àû µ¥ÀÌÅÍ 2018³â-2021³â ¿¹Ãø ±â°£ 2023-2030
¿¹Ãø ±â°£ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 9.30% 2030³â ½ÃÀå ±Ô¸ð ¿¹Ãø 46¾ï 9,000¸¸ ´Þ·¯
±×¸² 1. ¼¼°è ÁöÇ÷ ½ºÇÁ·¹ÀÌ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2023³â
Hemostatic Spray Market-IMG1

ÁöÇ÷ ½ºÇÁ·¹ÀÌ´Â ¼ö¼ú Áß ¹× ÀÀ±Þ »óȲ¿¡¼­ ÃâÇ÷À» Á¦¾îÇÏ´Â µ¥ µµ¿òÀ̵Ǵ Áß¿äÇÑ ÀÇ·á ±â¼ú Çõ½ÅÀÔ´Ï´Ù. ÀÌ ½ºÇÁ·¹ÀÌ´Â Ç÷Àü Çü¼ºÀ» ÃËÁøÇÏ¿© »óó¿¡ º¸È£ À庮À» ¸¸µé°í ½Å¼ÓÇϰí È¿À²ÀûÀ¸·Î ÃâÇ÷À» ÁßÁöÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ÁöÇ÷ ½ºÇÁ·¹ÀÌ´Â »ç¿ëÀÇ ¿ëÀ̼º, È¿´É ¹× ÃâÇ÷À» ÃÖ¼ÒÈ­ÇÏ´Â ´É·ÂÀ¸·Î °Ç°­ °ü¸® ¾÷°è¿¡¼­ ¾öû³­ Àα⸦ ¾ò°í ¼öÇ÷ÀÇ Çʿ伺À» ÁÙÀÔ´Ï´Ù. ÁöÇ÷ ½ºÇÁ·¹ÀÌ´Â ¼ö¼ú Áß ¶Ç´Â ÀÀ±Þ ½Ã ÁöÇ÷¿¡ »ç¿ëµÇ´Â ÀÇ·á Á¦Ç°ÀÔ´Ï´Ù. ÃâÇ÷ ºÎÀ§ À§¿¡ ÃþÀ» Çü¼ºÇϰí Ç÷¾×À» ÀÀ°í½ÃÄÑ ÁöÇ÷ÇÏ´Â ±â´ÉÀ» ÇÕ´Ï´Ù. ½ºÇÁ·¹ÀÌ¿¡´Â º¸Åë Æ®·ÒºóÀ̳ª ÇǺ긮³ë°Õ µî ÀÀ°í¸¦ ÃËÁøÇÏ´Â ¹°ÁúÀÌ Æ÷ÇԵǸç, Äݶó°ÕÀ̳ª Á©¶óƾ µî Á¶Á÷¿¡ Á¢ÂøÀ» µ½´Â ¹°ÁúÀÌ Æ÷Ç﵃ ¼ö ÀÖ½À´Ï´Ù. ½ºÇÁ·¹ÀÌ´Â ½ºÇÁ·¹ÀÌ ¿ë±â ¶Ç´Â Àü¿ë ÀåÄ¡¸¦ ÅëÇØ ÃâÇ÷ ºÎÀ§¿¡ Á÷Á¢ Àû¿ëµË´Ï´Ù. ÁöÇ÷ ½ºÇÁ·¹ÀÌ´Â ¼ö¼ú, ÀÀ±Þ ÀÇ·á, ¿Ü»ó Ä¡·á µî ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ »ç¿ëµË´Ï´Ù. ºÀÇÕ»ç¿Í ½ºÅ×ÀÌÇðú °°Àº ±âÁ¸ÀÇ ÁöÇ÷ ¹æ¹ýÀÌ È¿°úÀûÀÌÁö ¾Ê°í ½Ç¿ëÀûÀÌÁö ¾ÊÀº °æ¿ì ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ¼¼°è ÁöÇ÷ ½ºÇÁ·¹ÀÌ ½ÃÀåÀº Áõ°¡Çϰí ÀÖÀ¸¸ç, ±× ¹è°æ¿¡´Â ¼ö¼ú Áõ°¡, ¼ö¼úÀÌ ÇÊ¿äÇÑ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ÁöÇ÷ ½ºÇÁ·¹ÀÌ ±â¼úÀÇ ¹ßÀü µîÀÇ ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. ¼¼°è ÁöÇ÷ ½ºÇÁ·¹ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ±â¾÷Àº Baxter International, CR Bard, Johnson & Johnson µî ÀÌ·¯ÇÑ Á¦Ç°À» Á¦Á¶ ¹× ÆÇ¸ÅÇÏ´Â ±â¾÷À» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ È¸»çµéÀº ÁöÇ÷ ½ºÇÁ·¹ÀÌÀÇ È¿À²¼º°ú ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ°í ¿ëµµ¸¦ È®´ëÇϱâ À§ÇØ R&D¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

±ÔÁ¦ ´ç±¹ÀÇ Á¦Ç° ½ÂÀÎ Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î(2022³â) 9¿ù ÀÇ·á±â±â ȸ»çÀÎ Shilpa Medicare Limited´Â ÁöÇ÷ ½ºÇÁ·¹ÀÌÀÇ Áß¾Ó ÀǾàǰ Ç¥ÁØ °ü¸® ±â°ü(CDSCO)ÀÇ ½ÂÀÎÀ» ¹ßÇ¥Çß½À´Ï´Ù.

ÀÌ·¯ÇÑ °úÁ¦¿¡µµ ºÒ±¸ÇÏ°í ½ÃÀå¿¡´Â ¼ö¸¹Àº ¼ºÀå ±âȸ°¡ ÀÖ½À´Ï´Ù. ÁöÇ÷ ½ºÇÁ·¹ÀÌ Á¦ÇüÀÇ Áøº¸¿Í Çõ½ÅÀûÀÎ Àü´Þ ½Ã½ºÅÛÀÇ °³Ã´Àº ½ÃÀåÀ» È®´ë ÇÒ ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ½ÅÈï±¹¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶ó¸¦ °³¼±Çϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºêÀÌ µµÀԵǰí ÀÖ¾î ÁöÇ÷ ½ºÇÁ·¹ÀÌ ¼ö¿ä¸¦ ²ø¾î¿Ã¸± °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°è ÁöÇ÷ ½ºÇÁ·¹ÀÌ ½ÃÀå- Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°è ÁöÇ÷ ½ºÇÁ·¹ÀÌ ½ÃÀå : Á¦Ç° À¯Çüº°(2018³â-2030³â)

Á¦6Àå ¼¼°è ÁöÇ÷ ½ºÇÁ·¹ÀÌ ½ÃÀå : ¿ëµµº°(2018³â-2030³â)

Á¦7Àå ¼¼°è ÁöÇ÷ ½ºÇÁ·¹ÀÌ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2018³â-2030³â)

Á¦8Àå ¼¼°è ÁöÇ÷ ½ºÇÁ·¹ÀÌ ½ÃÀå : Áö¿ªº°(2018³â-2030³â)

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¼½¼Ç

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Hemostatic Spray Market size is expected to reach US$ 4.69 Bn by 2030, from US$ 2.51 Bn in 2023, at a CAGR of 9.3% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 2.51 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 9.30% 2030 Value Projection: US$ 4.69 Bn
Figure 1. Global Hemostatic Spray Market Share (%), By Region, 2023
Hemostatic Spray Market - IMG1

Hemostatic sprays are a vital medical innovation that aids in the control of bleeding during surgical procedures or in emergency situations. These sprays are designed to quickly and efficiently stop bleeding by promoting clot formation and thus creating a protective barrier over the wound. Hemostatic sprays have gained immense popularity in the healthcare industry due to their ease of use, effectiveness, and ability to minimize blood loss, thereby reducing the need for blood transfusions. Hemostatic spray is a medical product used to stop bleeding during surgical procedures or in emergency situations. It works by forming a layer over the bleeding area, which helps to clot the blood and stop the bleeding. The spray typically contains a substance that promotes clotting, such as thrombin or fibrinogen, and may also contain a substance to help adhere to the tissue, such as collagen or gelatin. The spray is applied directly to the bleeding area, either through a spray canister or a specialized device. Hemostatic sprays are used in a variety of medical settings, including surgery, emergency medicine, and trauma care. They are particularly useful in situations where traditional methods of controlling bleeding, such as sutures or staples, are not effective or practical. The global market for hemostatic sprays is increasing, which is driven by factors such as the increasing number of surgical procedures, the rising prevalence of chronic diseases that require surgery, and advancements in hemostatic spray technology. Key market players in the global hemostatic spray market include companies that manufacture and distribute these products, such as Baxter International, C.R. Bard, and Johnson & Johnson. These companies are investing in research and development (R&D) to improve the efficacy and safety of hemostatic sprays and to expand their applications.

Market Dynamics:

Increasing product approval by the regulatory bodies is expected to drive the growth of the market over the forecast period. For instance, in September 2022, Shilpa Medicare Limited, a medical device company, announced the Central Drugs Standard Control Organisation (CDSCO) approval of its hemostatic spray.

Despite these challenges, the market presents numerous opportunities for growth. Advancements in hemostatic spray formulations and the development of innovative delivery systems have the potential to expand the market. Moreover, the introduction of government initiatives to improve healthcare infrastructure, particularly in emerging economies, will likely boost the demand for hemostatic sprays.

Key features of the study:

Global Hemostatic Spray Market Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Hemostatic Spray Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Hemostatic Spray Market, By Product Type, 2018-2030, (US$ Bn)

6. Global Hemostatic Spray Market, By Application, 2018-2030, (US$ Bn)

7. Global Hemostatic Spray Market, By End User, 2018-2030, (US$ Bn)

8. Global Hemostatic Spray Market, By Region, 2018-2030, (US$ Bn)

9. Competitive Landscape

10. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â